A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis

Abstract

IL-10 at the 8-microg/kg i.v. dose was not effective in reducing the incidence or severity of ERCP-induced pancreatitis. Further investigations are necessary to determine if manipulation of the cytokine pathway can prevent ERCP-induced pancreatitis.